Related content

Reductions in overactive bladder-related incontinence from pooled analysis of phase III trials evaluating treatment with solifenacin

By Cardozo Linda   Castro-Diaz David   Gittelman Marc   Ridder Arwin   Huang Moses  

International Urogynecology Journal, Vol. 17, Iss. 5, 2006-10 ,pp. : 512-519

Springer Publishing Company

Access to resources Recommend Favorite

Effects of initial combined tamsulosin and solifenacin therapy for overactive bladder and bladder outlet obstruction secondary to benign prostatic hyperplasia: a prospective, randomized, multicenter study

By Lee Seung   Byun Seok   Lee Seung   Kim Khae   Lee Ji  

International Urology and Nephrology, Vol. 46, Iss. 3, 2014-03 ,pp. : 523-529

Springer Publishing Company

Access to resources Recommend Favorite

Nocturnal polyuria and nocturia relief in patients treated with solifenacin for overactive bladder symptoms

By Brubaker Linda   FitzGerald Mary  

International Urogynecology Journal, Vol. 18, Iss. 7, 2007-07 ,pp. : 737-741

Springer Publishing Company

Access to resources Recommend Favorite

Tolterodine in the treatment of overactive bladder: analysis of the pooled phase II efficacy and safety data - oxybutynin versus propantheline versus placebo

By Larsson G.   Hallen B.   Nilvebrant L.  

Urology, Vol. 53, Iss. 5, 1999-05 ,pp. : 990-998

Elsevier

Access to resources Recommend Favorite

Health-related quality of life among adults with symptoms of overactive bladder: results from a U.S. community-based survey

By Liberman J.N.   Hunt T.L.   Stewart W.F.   Wein A.   Zhou Z.   Herzog A.R.   Lipton R.B.   Diokno A.C.  

Urology, Vol. 57, Iss. 6, 2001-06 ,pp. : 1044-1050

Elsevier

Access to resources Recommend Favorite